DM news - meters and new study

[Cowboyjim]

I have a job that means I have to look at the newsfeeds for health and I come across some interesting DM-related stuff I thought I would pass on.

In the US health regulators are looking at how well devices used by diabetics to monitor their blood sugars work, seeking possible changes for meter makers to help make them more reliable.
At a two-day meeting to review blood glucose meters, FDA pointed to a number of issues that can prevent people from getting proper treatment and sought input from medical experts and industry on ways to improve test results with the widely used devices. It gets about 12,000 reports of errors with such meters each year and is currently weighing new industry guidelines. Such errors are likely underreported, but must be weighed against the billions of glucose tests done annually as patients test their sugars several times a day...

Newswires have a report on study results showing that dapagliflozin treatment improves the glycemic control and body weight of both early and late-stage Type 2 diabetics.

Finally, as much as $75 million in popular Eli Lilly & Co prescription medicines such as Prozac were stolen during a raging storm from a Connecticut warehouse over the weekend...

 

[hanadr]

You can bet that the UK medic authorities won't be taking much notice on meter accuracy. They are ONLY concerned with the cost and how they can cut down on strip use. I've even heard of pumping children being restricted.
Hana

 

[iHs]

I hope that Dapagliflozin eventually becomes available in the UK. Someone on this forum took part in a clinical trial for it I think about 1 or 2 years ago and it looks fairly promising.

 

[Cowboyjim]

More DM news today with the US FDA accepting for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.

ONGLYZA has been submitted for regulatory review in more than 50 countries and is approved in 38 countries, including the US and member states of the EU. ONGLYZA was approved by the FDA in July 2009 and is indicated as an adjunct to diet and exercise to improve blood sugar control in adults for the treatment of type 2. One daily can be used in combination with commonly prescribed oral anti-diabetic medications – metformin, sulfonylureas or thiazolidinediones (TZD) – or as a monotherapy to significantly reduce glycosylated hemoglobin (A1C) levels.

Further to the Lilly heist at the weekend the company issued an official statement: "Since early Sunday morning, Lilly has taken quick and appropriate actions to ensure the safety of our medicines," said Dr. Fionnuala M. Walsh, Lilly's senior vice president of global quality. "The U.S. pharmaceutical distribution system is tightly controlled and monitored, making it extremely difficult for stolen product to make it to patients through legitimate channels. However, we will continue to work closely with local and federal law enforcement authorities, the FDA, and our distribution partners to maintain the integrity of our drug supply chain."
There's a reward for info on their website I think....
Apparently the crooks cut through a ceiling and rappelled inside.... cracking drugs here Grommit! They had disarmed the alarms and stole enough pallets of drugs to fill at least one tractor-trailer. Web experts say it is the largest heist of its kind... wow, there's a challenge. Can't see what type of drugs WP says they are Mother's Helpers and unspecific 'others'.

 

[Cowboyjim]

Re: DM news - meters and new study Seroquel

Apparently AstraZeneca PLC 's psychiatric drug Seroquel did not trigger diabetes in a Vietnam veteran, a jury ruled in the first trial out of thousands of cases alleging the drug caused diabetes. It said a jury in Middlesex County Superior Court in NJ voted 7 to 1 in favor of the company, after deliberating for seven hours over the past two days.